R90.0

Clinical Causes: Benign tumors (e.g., meningiomas, schwannomas) Malignant tumors (e.g., gliomas, metastatic tumors) Infections leading to abscess formation Vascular anomalies such as arteriovenous malformations Cysts or fluid-filled cavities Degenerative or inflammatory conditions causing abnormal tissue growth Trauma-related hematomas or swelling

Key Symptoms: Headaches, often worsening over time Seizures or convulsions Nausea and vomiting Changes in vision or hearing Weakness or numbness in limbs Difficulty with balance or coordination Cognitive disturbances, confusion, or personality changes Loss of consciousness in severe cases

Diagnosis Path: The detection of intracranial space-occupying lesions primarily involves neuroimaging techniques. These include magnetic resonance imaging (MRI), which offers detailed visualization of brain structures, and computed tomography (CT) scans, especially useful in emergency settings. Additional procedures such as biopsy may be performed to determine the precise nature of the lesion, whether benign or malignant. Clinical evaluation combined with detailed imaging helps healthcare professionals assess the lesion's size, location, and potential impact.

Treatment Protocols: Treatment strategies depend on the type, size, location, and underlying cause of the lesion. Options may include surgical removal or biopsy, radiation therapy, chemotherapy, or targeted medical therapies. In cases where surgery is not feasible, conservative management with medications to control symptoms may be considered. Regular monitoring through follow-up imaging is crucial for assessing progression or response to treatment. Multidisciplinary care involving neurosurgeons, neurologists, and oncologists is often essential for optimal management.